HighTower Advisors
AMPH icon

HighTower Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

HighTower Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,875
Closed -$792K – 3622
2023
Q4 		$792K Buy
12,875
+6,886
+115% +$362K ﹤0.01% 1979
2023
Q3 		$279K Sell
5,989
-5,947
-50% -$324K ﹤0.01% 2652
2023
Q2 		$682K Sell
11,936
-106
-0.9% -$4.7K ﹤0.01% 1995
2023
Q1 		$459K Buy
12,042
+1,983
+20% +$65K ﹤0.01% 2174
2022
Q4 		$282K Buy
+10,059
New +$292K ﹤0.01% 2510

Other funds holding AMPH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return